116 related articles for article (PubMed ID: 7648800)
1. Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro.
Kawamura T; Suzuki K; Matsumae H; Sano T; Sakamoto N; Hotta N
Diabet Med; 1995 May; 12(5):392-6. PubMed ID: 7648800
[TBL] [Abstract][Full Text] [Related]
2. Effect of aldose reductase inhibitors on glucose-induced changes in sorbitol and myo-inositol metabolism in human neutrophils.
Suzuki K; Kawamura T; Sakakibara F; Sasaki H; Sano T; Sakamoto N; Hotta N
Diabet Med; 1999 Jan; 16(1):67-73. PubMed ID: 10229296
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
4. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
[TBL] [Abstract][Full Text] [Related]
5. Fidarestat (SNK-860), a potent aldose reductase inhibitor, normalizes the elevated sorbitol accumulation in erythrocytes of diabetic patients.
Asano T; Saito Y; Kawakami M; Yamada N;
J Diabetes Complications; 2002; 16(2):133-8. PubMed ID: 12039395
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of orally administered aldose reductase inhibitor SNK-860 on corneal polyol accumulation in galactose-fed rats.
Kubo E; Nakamura S; Tsuzuki S; Takahashi Y; Akagi Y; Mizuno K; Matsubara A
Graefes Arch Clin Exp Ophthalmol; 1999 Sep; 237(9):758-62. PubMed ID: 10447652
[TBL] [Abstract][Full Text] [Related]
7. The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrations.
Lorenzi M; Toledo S; Boss GR; Lane MJ; Montisano DF
Diabetologia; 1987 Apr; 30(4):222-7. PubMed ID: 3109991
[TBL] [Abstract][Full Text] [Related]
8. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 1: A hypertonicity-induced protein enhances myo-inositol transport.
Cammarata PR; Chen HQ
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1223-35. PubMed ID: 8125733
[TBL] [Abstract][Full Text] [Related]
9. Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor.
Kuruvilla R; Eichberg J
J Neurochem; 1998 Aug; 71(2):775-83. PubMed ID: 9681469
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil sorbitol production impairs oxidative killing in diabetes.
Wilson RM; Tomlinson DR; Reeves WG
Diabet Med; 1987; 4(1):37-40. PubMed ID: 2951217
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
[TBL] [Abstract][Full Text] [Related]
12. Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients.
Ihm SH; Yoo HJ; Park SW; Park CJ
Metabolism; 1997 Jun; 46(6):634-8. PubMed ID: 9186297
[TBL] [Abstract][Full Text] [Related]
13. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells.
Haneda M; Kikkawa R; Arimura T; Ebata K; Togawa M; Maeda S; Sawada T; Horide N; Shigeta Y
Metabolism; 1990 Jan; 39(1):40-5. PubMed ID: 2104641
[TBL] [Abstract][Full Text] [Related]
14. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent.
Wong TY; Phillips AO; Witowski J; Topley N
Kidney Int; 2003 Apr; 63(4):1404-16. PubMed ID: 12631356
[TBL] [Abstract][Full Text] [Related]
15. The influence of aldose reductase on the oxidative burst in diabetic neutrophils.
Tebbs SE; Lumbwe CM; Tesfaye S; Gonzalez AM; Wilson RM
Diabetes Res Clin Pract; 1992 Feb; 15(2):121-9. PubMed ID: 1314160
[TBL] [Abstract][Full Text] [Related]
16. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
[TBL] [Abstract][Full Text] [Related]
17. Modulation of myo-[3H]inositol uptake by glucose and sorbitol in cultured bovine lens epithelial cells. I. Restoration of myo-inositol uptake by aldose reductase inhibition.
Cammarata PR; Chen HQ; Yang J; Yorio T
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3561-71. PubMed ID: 1464502
[TBL] [Abstract][Full Text] [Related]
18. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus.
Bareford D; Jennings PE; Stone PC; Baar S; Barnett AH; Stuart J
J Clin Pathol; 1986 Jul; 39(7):722-7. PubMed ID: 3090107
[TBL] [Abstract][Full Text] [Related]
19. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent.
Morrisey K; Steadman R; Williams JD; Phillips AO
Kidney Int; 1999 Jan; 55(1):160-7. PubMed ID: 9893124
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase gene expression and osmotic dysregulation in cultured human retinal pigment epithelial cells.
Stevens MJ; Henry DN; Thomas TP; Killen PD; Greene DA
Am J Physiol; 1993 Sep; 265(3 Pt 1):E428-38. PubMed ID: 8214052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
